Quest Diagnostics price target raised to $180 from $165 at Piper Sandler
Piper Sandler analyst David Westenberg raised the firm’s price target on Quest Diagnostics (DGX) to $180 from $165 and keeps a Neutral rating ...
Evercore ISI Remains a Hold on Quest Diagnostics (DGX)
In a report released on January 31, Elizabeth Anderson CFA from Evercore ISI maintained a Hold rating on Quest Diagnostics (DGX – Research ...
Earnings call transcript: Quest Diagnostics Q4 2024 beats EPS forecast
Following the earnings announcement, Quest Diagnostics (NYSE:DGX)' stock price rose by 0.48% in pre-market trading. The stock ...
Quest Diagnostics Incorporated (NYSE:DGX) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript January 30, 2025 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is $2.33, expectations were $2.19. Operator: Welcome to the Quest Diagnostics ...